Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuko Furuya

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Journal of Clinical Pathology|May 8, 2020
Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomasMitsuko Furuya, Yasuhiro Iribe, Yoji Nagashima, et al.
Biochemical and Biophysical Research Communications|December 7, 2019
FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary glandYasuhiro Isono, Mitsuko Furuya, Tatsu Kuwahara, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 14, 2025
HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid SynthesisHidekazu Nishizawa, Shintaro Funasaki, Wenjuan Ma, et al.
Human Molecular Genetics|December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferationHisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Human Molecular Genetics|May 17, 2018
BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genesHisashi Hasumi, Mitsuko Furuya, Kenji Tatsuno, et al.
Biochemical and Biophysical Research Communications|October 4, 2024
SETD2 regulates SLC family transporter-mediated sodium and glucose reabsorptions in renal tubuleTaku Mitome, Hiromichi Wakui, Kengo Azushima, et al.
Molecular Cancer Research : MCR|May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseMasaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Iscience|July 25, 2022
Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancersRyosuke Jikuya, Koichi Murakami, Akira Nishiyama, et al.
Molecular Cancer Research : MCR|December 22, 2025
Genetically engineered human iPS cell-derived kidney organoid recapitulates an early stage of ALK fusion gene-associated renal tumorigenesisGo Noguchi, Masaya Baba, Shinji Ohtake, et al.
Ebiomedicine|May 14, 2023
Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinomaRyosuke Jikuya, Todd A Johnson, Kazuhiro Maejima, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Journal of Clinical Pathology|May 8, 2020
Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomasMitsuko Furuya, Yasuhiro Iribe, Yoji Nagashima, et al.
Biochemical and Biophysical Research Communications|December 7, 2019
FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary glandYasuhiro Isono, Mitsuko Furuya, Tatsu Kuwahara, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|January 14, 2025
HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid SynthesisHidekazu Nishizawa, Shintaro Funasaki, Wenjuan Ma, et al.
Human Molecular Genetics|December 24, 2016
H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferationHisashi Hasumi, Yukiko Hasumi, Masaya Baba, et al.
Human Molecular Genetics|May 17, 2018
BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genesHisashi Hasumi, Mitsuko Furuya, Kenji Tatsuno, et al.
Biochemical and Biophysical Research Communications|October 4, 2024
SETD2 regulates SLC family transporter-mediated sodium and glucose reabsorptions in renal tubuleTaku Mitome, Hiromichi Wakui, Kengo Azushima, et al.
Molecular Cancer Research : MCR|May 3, 2019
TFE3 Xp11.2 Translocation Renal Cell Carcinoma Mouse Model Reveals Novel Therapeutic Targets and Identifies GPNMB as a Diagnostic Marker for Human DiseaseMasaya Baba, Mitsuko Furuya, Takanobu Motoshima, et al.
Iscience|July 25, 2022
Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancersRyosuke Jikuya, Koichi Murakami, Akira Nishiyama, et al.
Molecular Cancer Research : MCR|December 22, 2025
Genetically engineered human iPS cell-derived kidney organoid recapitulates an early stage of ALK fusion gene-associated renal tumorigenesisGo Noguchi, Masaya Baba, Shinji Ohtake, et al.
Ebiomedicine|May 14, 2023
Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinomaRyosuke Jikuya, Todd A Johnson, Kazuhiro Maejima, et al.
Pageof 11